Results 31 to 40 of about 4,073,186 (254)
Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality.
Virani, Salim S. +9 more
core +1 more source
La sindrome cardio-nefro-metabolica
Introduzione M. Meschi, D. Manfellotto, A. Montagnani Aspetti clinici e diagnostici della cardiovascular-kidney-metabolic syndrome A. Montagnani, A. Rustici, M.
Andrea Montagnani, Dario Manfellotto
doaj +1 more source
Metabolic Syndrome and Outcomes after Renal Intervention
Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity.
Daynene Vykoukal, Mark G. Davies
doaj +1 more source
Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study [PDF]
BACKGROUND: In patients with chronic kidney disease, metabolic syndrome has been demonstrated to be the culprit behind diverse complications. Adiponectin is known to have anti-atherogenic and cardio-protective effects. Meanwhile, the relationship between
최규헌 +3 more
core +1 more source
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The
Virani, Salim S. +12 more
core +1 more source
In 2023, the American Heart Association for the first time formally defined cardiovascular-kidney-metabolic (CKM) syndrome as a systemic disease characterized by pathophysiological interactions between metabolic risk factors, chronic kidney disease (CKD),
G. G. Arabidze, M. N. Mamedov
doaj +1 more source
Exercise rehabilitation in cardiovascular-kidney-metabolic syndrome: a narrative review
Cardiovascular-Kidney-Metabolic Syndrome (CKM) is a multi-organ dysfunction syndrome driven by the interaction of metabolic risk factors, chronic kidney disease, and cardiovascular disease, culminating in adverse cardiovascular events.
Min Sun +4 more
doaj +1 more source
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley +1 more source
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley +1 more source
Renal Replacement Therapy in CKM: Challenges for Dialytic Therapies and Kidney Transplantation
Cardiovascular-kidney-metabolic (CKM) syndrome integrates the strong interrelationship among cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors such as obesity and diabetes.
Mahtab Mashayekhi +5 more
doaj +1 more source

